Calcitriol Promotes Differentiation of Glioma Stem-Like Cells and Increases Their Susceptibility to Temozolomide
Glioblastoma (GBM) is the most common and most aggressive primary brain tumor, with a very high rate of recurrence and a median survival of 15 months after diagnosis. Abundant evidence suggests that a certain sub-population of cancer cells harbors a stem-like phenotype and is likely responsible for...
Main Authors: | Julia Gerstmeier, Anna-Lena Possmayer, Süleyman Bozkurt, Marina E. Hoffmann, Ivan Dikic, Christel Herold-Mende, Michael C. Burger, Christian Münch, Donat Kögel, Benedikt Linder |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/14/3577 |
Similar Items
-
Arsenic Trioxide and (−)-Gossypol Synergistically Target Glioma Stem-Like Cells via Inhibition of Hedgehog and Notch Signaling
by: Benedikt Linder, et al.
Published: (2019-03-01) -
Synergistic Effect of Perampanel and Temozolomide in Human Glioma Cell Lines
by: Andrea Salmaggi, et al.
Published: (2021-05-01) -
Optimising Outcomes for Glioblastoma through Subspecialisation in a Regional Cancer Centre
by: Michael Back, et al.
Published: (2018-10-01) -
Vitamin D Metabolite Profile in Cholecalciferol- or Calcitriol-Supplemented Healthy and Mammary Gland Tumor-Bearing Mice
by: Artur Anisiewicz, et al.
Published: (2020-11-01) -
Combination hyperbaric oxygen and temozolomide therapy in c6 rat glioma model Terapia combinada de oxigênio hiperbárico e temozomida no modelo C6 de glioma em ratos
by: Yaşar Dagıstan, et al.
Published: (2012-06-01)